Author

Cunningham EB

November 14, 2018
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake – a modeling study
Summary Subsidized direct-acting antiviral (DAA) treatment recently became available to all adults living with chronic hepatitis C (HCV) in Australia. Based on rapid uptake (32,600 people initiated DAA in 2016) we estimated the impact on HCV epidemiology and mortality in Australia and determined if Australia can meet the WHO HCV elimination targets by 2030. Using […]

Read More
August 28, 2018
Global, regional, and country-level estimates of hepatitis C virus infection among people who have recently injected drugs
Summary Background and Aims People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with HCV, and the proportion of people with recent injecting drug use among all people living with […]

Read More